Philips Secures FDA Approval for AI-Enhanced Spectral Scanner
Royal Philips has announced receiving FDA 510(k) clearance for its Spectral CT Verida system, which incorporates spectral imaging and AI-driven reconstruction. This system enters the American market following development based on the company's spectral technology.
Advanced Imaging and AI Integration
The Verida system incorporates the Spectral Precise Image technology, which combines a third-generation dual-layer Nano-panel Precise detector with intrinsic noise reduction, along with a deep learning reconstruction engine. This design aims to reduce noise and enhance image quality in scanner applications. The system is intended for use in radiology, interventional radiology, cardiology, and oncology, including low-dose lung cancer screening according to established protocols.
Enhanced Speed and Efficiency in Spectral Imaging
Leveraging the group's detector-based spectral technology, Verida enables continuous spectral imaging without additional examinations or changes to clinical processes. The system reconstructs 145 images per second, making full examinations available in less than 30 seconds, which is twice as fast as previous capabilities. By simultaneously capturing high and low energy data in a single acquisition, clinicians can access both conventional and spectral results at the same time, allowing for improved tissue characterization and material differentiation without the need for pre-selection or repeated scans.
